PT3600363T - Composições compreendendo estirpes bacterianas - Google Patents
Composições compreendendo estirpes bacterianasInfo
- Publication number
- PT3600363T PT3600363T PT187318191T PT18731819T PT3600363T PT 3600363 T PT3600363 T PT 3600363T PT 187318191 T PT187318191 T PT 187318191T PT 18731819 T PT18731819 T PT 18731819T PT 3600363 T PT3600363 T PT 3600363T
- Authority
- PT
- Portugal
- Prior art keywords
- compositions
- bacterial strains
- strains
- bacterial
- Prior art date
Links
- 230000001580 bacterial effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Physiology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Psychology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1709465.7A GB201709465D0 (en) | 2017-06-14 | 2017-06-14 | Compositions comprising bacterial strains |
GBGB1709526.6A GB201709526D0 (en) | 2017-06-15 | 2017-06-15 | Compositions comprising bacterial strains |
GBGB1805991.5A GB201805991D0 (en) | 2018-04-11 | 2018-04-11 | Compositions comprising bacterial strains |
GBGB1805989.9A GB201805989D0 (en) | 2018-04-11 | 2018-04-11 | Compositions comprising bacterial strains |
GBGB1805990.7A GB201805990D0 (en) | 2018-04-11 | 2018-04-11 | Compostions comprising bacterial strains |
GBGB1806780.1A GB201806780D0 (en) | 2018-04-25 | 2018-04-25 | Compositions comprising bacterial strains |
GBGB1806779.3A GB201806779D0 (en) | 2018-04-25 | 2018-04-25 | Compositions comprising bacterial strains |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3600363T true PT3600363T (pt) | 2021-02-03 |
Family
ID=62631106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT187318191T PT3600363T (pt) | 2017-06-14 | 2018-06-14 | Composições compreendendo estirpes bacterianas |
Country Status (23)
Country | Link |
---|---|
US (1) | US20200171102A1 (pt) |
EP (2) | EP3600363B1 (pt) |
JP (2) | JP6840272B2 (pt) |
KR (1) | KR102521444B1 (pt) |
CN (2) | CN111107859B (pt) |
AU (2) | AU2018285445B2 (pt) |
BR (1) | BR112019026477A2 (pt) |
CA (1) | CA3066189A1 (pt) |
CY (1) | CY1123857T1 (pt) |
DK (1) | DK3600363T3 (pt) |
ES (1) | ES2855701T3 (pt) |
HR (1) | HRP20210205T1 (pt) |
HU (1) | HUE053488T2 (pt) |
IL (2) | IL283973B (pt) |
LT (1) | LT3600363T (pt) |
MD (1) | MD3600363T2 (pt) |
PL (1) | PL3600363T3 (pt) |
PT (1) | PT3600363T (pt) |
RS (1) | RS61367B1 (pt) |
SG (1) | SG11201912105PA (pt) |
SI (1) | SI3600363T1 (pt) |
TW (1) | TWI767013B (pt) |
WO (1) | WO2018229189A1 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3600364B1 (en) | 2017-06-14 | 2020-08-05 | 4D Pharma Research Limited | Compositions comprising a bacterial strain of the genus megasphaera and uses thereof |
MD3600363T2 (ro) * | 2017-06-14 | 2021-05-31 | 4D Pharma Res Ltd | Compoziții cuprinzând tulpini bacteriene |
ES2916601T3 (es) | 2018-05-11 | 2022-07-04 | 4D Pharma Res Ltd | Composiciones que comprenden cepas bacterianas |
CN112410242A (zh) * | 2020-08-25 | 2021-02-26 | 上海市第十人民医院 | 一株分离自直肠癌肿瘤组织的狄氏副拟杆菌株及其应用 |
WO2023001368A1 (en) * | 2021-07-20 | 2023-01-26 | Université Catholique de Louvain | Prevention and/or treatment of reward dysregulation disorders |
KR20240040089A (ko) * | 2021-07-20 | 2024-03-27 | 위니베르시트카솔리끄드루뱅 | 보상 조절 장애의 방지 및/또는 치료 |
CN113750121A (zh) * | 2021-08-20 | 2021-12-07 | 上海交通大学医学院附属瑞金医院 | 一种狄氏副拟杆菌在制备阿尔茨海默病药物制剂中的应用 |
WO2023164591A2 (en) * | 2022-02-23 | 2023-08-31 | Metagenomi, Inc. | Systems and methods for transposing cargo nucleotide sequences |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPQ899700A0 (en) * | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
GB0127916D0 (en) | 2001-11-21 | 2002-01-16 | Rowett Res Inst | Method |
US20040005304A1 (en) * | 2002-07-08 | 2004-01-08 | Mak Wood, Inc. | Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions |
US20100168410A1 (en) | 2006-10-27 | 2010-07-01 | Pfizer Products Inc. | Hydroxypropyl Methyl Cellulose Hard Capsules and Process of Manufacture |
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
ES2582284T3 (es) * | 2011-10-11 | 2016-09-12 | Achim Biotherapeutics Ab | Composición que comprende microbiota intestinal humana anaeróbicamente cultivada |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
CN104546934B (zh) * | 2014-09-30 | 2019-04-09 | 深圳华大基因科技有限公司 | 粪副拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用 |
SE1550189A1 (en) * | 2015-02-19 | 2016-08-20 | Achim Biotherapeutics Ab | Therapeutic and prophylactic composition produced by microbiota |
MA41060B1 (fr) * | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
SG10201912324XA (en) * | 2015-06-15 | 2020-02-27 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
JP6895961B2 (ja) * | 2015-11-03 | 2021-06-30 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドThe Brigham and Women’s Hospital, Inc. | 食物アレルギーの処置および/または防止のための治療用微生物叢 |
CA3016911A1 (en) * | 2016-03-14 | 2017-09-21 | Holobiome, Inc. | Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system |
AU2017382197B2 (en) * | 2016-12-20 | 2022-12-01 | The Regents Of The University Of California | Compositions and methods for inhibiting seizures |
MD3600363T2 (ro) * | 2017-06-14 | 2021-05-31 | 4D Pharma Res Ltd | Compoziții cuprinzând tulpini bacteriene |
US20210364526A1 (en) * | 2018-05-23 | 2021-11-25 | The Regents Of The University Of California | Methods of selecting subjects for treatment with metabolomic modulators |
-
2018
- 2018-06-14 MD MDE20200143T patent/MD3600363T2/ro unknown
- 2018-06-14 CA CA3066189A patent/CA3066189A1/en not_active Abandoned
- 2018-06-14 PT PT187318191T patent/PT3600363T/pt unknown
- 2018-06-14 TW TW107120603A patent/TWI767013B/zh active
- 2018-06-14 WO PCT/EP2018/065809 patent/WO2018229189A1/en active Search and Examination
- 2018-06-14 RS RS20210088A patent/RS61367B1/sr unknown
- 2018-06-14 LT LTEP18731819.1T patent/LT3600363T/lt unknown
- 2018-06-14 PL PL18731819T patent/PL3600363T3/pl unknown
- 2018-06-14 BR BR112019026477-9A patent/BR112019026477A2/pt unknown
- 2018-06-14 EP EP18731819.1A patent/EP3600363B1/en active Active
- 2018-06-14 DK DK18731819.1T patent/DK3600363T3/da active
- 2018-06-14 SI SI201830161T patent/SI3600363T1/sl unknown
- 2018-06-14 AU AU2018285445A patent/AU2018285445B2/en active Active
- 2018-06-14 EP EP20210763.7A patent/EP3858367A1/en active Pending
- 2018-06-14 IL IL283973A patent/IL283973B/en unknown
- 2018-06-14 KR KR1020197037443A patent/KR102521444B1/ko active IP Right Grant
- 2018-06-14 SG SG11201912105PA patent/SG11201912105PA/en unknown
- 2018-06-14 ES ES18731819T patent/ES2855701T3/es active Active
- 2018-06-14 CN CN201880039720.5A patent/CN111107859B/zh active Active
- 2018-06-14 HU HUE18731819A patent/HUE053488T2/hu unknown
- 2018-06-14 JP JP2019567619A patent/JP6840272B2/ja active Active
- 2018-06-14 CN CN202210381608.8A patent/CN115813955A/zh active Pending
-
2019
- 2019-12-03 IL IL271152A patent/IL271152B/en active IP Right Grant
- 2019-12-13 US US16/714,023 patent/US20200171102A1/en active Pending
-
2020
- 2020-06-26 AU AU2020204265A patent/AU2020204265A1/en not_active Abandoned
-
2021
- 2021-02-05 HR HRP20210205TT patent/HRP20210205T1/hr unknown
- 2021-02-15 CY CY20211100127T patent/CY1123857T1/el unknown
- 2021-02-16 JP JP2021022774A patent/JP2021080269A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL271319A (en) | Preparations containing bacterial strains | |
IL283973A (en) | Preparations containing bacterial strains | |
PT3638271T (pt) | Composições contendo estirpes bacterianas | |
LT3630136T (lt) | Kompozicijos, apimančios bakterines padermes | |
GB201708182D0 (en) | Compositions comprising bacterial strains | |
IL272491A (en) | Preparations containing bacterial strains | |
GB201718551D0 (en) | Compositions comprising bacterial strains | |
GB201714298D0 (en) | Compositions comprising bacterial strains | |
GB201714309D0 (en) | Compositions comprising bacterial strains | |
GB201714305D0 (en) | Compositions comprising bacterial strains | |
GB201712857D0 (en) | Compositions comprising bacterial strains | |
GB201712851D0 (en) | Compositions comprising bacterial strains | |
GB201709526D0 (en) | Compositions comprising bacterial strains | |
GB201709533D0 (en) | Compositions comprising bacterial strains | |
GB201709534D0 (en) | Compositions comprising bacterial strains | |
GB201709466D0 (en) | Compositions comprising bacterial strains | |
GB201709465D0 (en) | Compositions comprising bacterial strains | |
GB201709468D0 (en) | Compositions comprising bacterial strains | |
GB201708176D0 (en) | Compositions comprising bacterial strains | |
GB201703548D0 (en) | Compositions comprising bacterial strains | |
GB201703552D0 (en) | Compositions comprising bacterial strains | |
GB201604920D0 (en) | Compositions comprising bacterial strains | |
GB201604566D0 (en) | Compositions comprising bacterial strains | |
GB201603786D0 (en) | Compositions comprising bacterial strains | |
GB201603817D0 (en) | Compositions comprising bacterial strains |